3-Month, prospective evaluation of cardiometabolic effects of second-generation antipsychotics in antipsychotic-naive and -exposed youth with severe mental disorders

被引：0
|
作者：
Carbon-Correll, M. [1 ]
Guinart, D. [2 ]
Kane, J. [3 ]
Correll, C. [4 ]
机构：
[1] Zucker Hillside Hosp, Psychiat, Glen Oaks, NY USA
[2] Zucker Hillside Hosp, Div Psychiat Res, New York, NY USA
[3] Northwell Hlth, Zucker Hillside Hosp, Dept Psychiat Res, Glen Oaks, NY USA
[4] Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA
来源：
EUROPEAN PSYCHIATRY | 2020年 / 63卷
关键词：
antipsychotic; Side Effects; Children and adolescents; metabolic side effects;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0179
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 21 条
  • [1] Age-Dependent Metabolic Effects of Second-Generation Antipsychotics in Second-Generation Antipsychotic-Naive French Canadian Patients
    Roy, Genevieve
    Bedard, Alain
    Desmarais, Paul-Andre
    Jourdain, France
    Allen, Sylvie
    Michaud, Danielle
    Ben Amor, Leila
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 479 - 487
  • [2] Metabolic side effects of second generation antipsychotic agents in antipsychotic-naive patients: One-month prospective evaluation
    Tarricone, Ilaria
    Serretti, Alessandro
    Gozzi, Beatrice Ferrari
    Mandelli, Laura
    Grieco, Daniela
    Mellim, Lorenzo
    Biagim, Stefano
    Berti, Beatrice
    Berardi, Domenico
    [J]. PSYCHIATRY RESEARCH, 2008, 157 (1-3) : 269 - 271
  • [3] Metabolic side effects with second generation antipsychotics in antipsychotic-naive adolescents
    Fraguas, D.
    Laita, P.
    Parellada, M.
    Moreno, D.
    Cifuentes, A.
    Ulloa, A.
    Lozano, R.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S71 - S71
  • [4] METABOLIC SIDE EFFECTS IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS AFTER 12 MONTHS OF TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS
    Pina, Laura
    Merchan-Naranjo, Jessica
    Garcia-Amador, Margarita
    Arango, Celso
    [J]. SCHIZOPHRENIA BULLETIN, 2011, 37 : 29 - 29
  • [5] Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia
    Lencer, Rebekka
    Sprenger, Andreas
    Harris, Margret S. H.
    Reilly, James L.
    Keshavan, Matcheri S.
    Sweeney, John A.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (10) : 1146 - 1154
  • [6] Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia
    Lencer, Rebekka
    Sprenger, Andreas
    Harris, Margret S. H.
    Reilly, James L.
    Keshavan, Matcheri S.
    Sweeney, John A.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 124S - 125S
  • [7] CHANGES IN LEPTIN, ADIPONECTIN AND GHRELIN IN ANTIPSYCHOTIC-NAIVE ADOLESCENTS TAKING SECOND-GENERATION ANTIPSYCHOTICS: COMPARATIVE EFFECTS IN PATIENTS WITH PSYCHOTIC AND NONPSYCHOTIC DISORDERS
    Pina-Camacho, Laura
    Merida, Elena
    Diaz-Caneja, Covadonga M.
    Tapia-Casellas, Cecilia
    Rodriguez-Latorre, Pamela
    Merchan-Naranjo, Jessica
    Fraguas, David
    Moreno, Carmen
    Parellada, Mara
    Arango, Celso
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S208 - S208
  • [8] Second-generation antipsychotics activate platelets in antipsychotic-naive and antipsychotic-free patients with schizophrenia: A retrospective study
    Kim, Hyun-Ah
    Lee, Jong Wook
    Kim, Seung Jun
    Oh, Hong-Seok
    Im, Woo Young
    Kim, Ji-Woong
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2020, 55 (02): : 105 - 113
  • [9] Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naive children and adolescents
    Diaz-Caneja, C. M.
    Giraldez-Quiroga, M.
    Merchan-Naranjo, J.
    Pina-Camacho, L.
    Tapia-Casellas, C.
    Rodriguez-Latorre, P.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S71 - S72
  • [10] Weight and metabolic risk associated with second-generation antipsychotics in antipsychotic-naive children and adolescents: A 12 month follow-up study
    Andreu, A.
    Pina-Camacho, L.
    Diaz-Caneja, C.
    Fraguas, D.
    Arango, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S552 - S553
123